These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 12830733)
1. Targeted therapies for the treatment of leukemia. Stull DM Semin Oncol Nurs; 2003 May; 19(2):90-7. PubMed ID: 12830733 [TBL] [Abstract][Full Text] [Related]
2. [Arsenic treatment for leukemia: new model of human cancer target treatment]. Zhao WW; Chen SJ Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):439-40. PubMed ID: 15854545 [No Abstract] [Full Text] [Related]
3. Old, new drugs and new, new drugs for the new millennium. Scheinberg DA Curr Oncol Rep; 2000 Mar; 2(2):112-3. PubMed ID: 11122831 [No Abstract] [Full Text] [Related]
4. Innovations in antineoplastic therapy. Kaplow R Nurs Clin North Am; 2005 Mar; 40(1):77-94. PubMed ID: 15733948 [TBL] [Abstract][Full Text] [Related]
5. From dissection of disease pathogenesis to elucidation of mechanisms of targeted therapies: leukemia research in the genomic era. Zhou GB; Li G; Chen SJ; Chen Z Acta Pharmacol Sin; 2007 Sep; 28(9):1434-49. PubMed ID: 17723177 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis, treatment, and nursing care of acute leukemia. Viele CS Semin Oncol Nurs; 2003 May; 19(2):98-108. PubMed ID: 12830734 [TBL] [Abstract][Full Text] [Related]
7. Hematopoietic cell transplantation in the treatment of leukemia. Devine H; DeMeyer E Semin Oncol Nurs; 2003 May; 19(2):118-32. PubMed ID: 12830736 [TBL] [Abstract][Full Text] [Related]
12. Novel agents aiming at specific molecular targets increase chemosensitivity and overcome chemoresistance in hematopoietic malignancies. Boehrer S; Nowak D; Hoelzer D; Mitrou PS; Chow KU Curr Pharm Des; 2006; 12(1):111-28. PubMed ID: 16454729 [TBL] [Abstract][Full Text] [Related]
13. Nursing considerations for nontraditional treatment approaches to hematologic malignancies. ONS News; 2004; 19(9 Suppl):67-8. PubMed ID: 15478594 [TBL] [Abstract][Full Text] [Related]
14. Decision-making in the diagnosis and treatment of leukemia. Shannon-Dorcy K; Wolfe V Semin Oncol Nurs; 2003 May; 19(2):142-9. PubMed ID: 12830738 [TBL] [Abstract][Full Text] [Related]
15. An overview of targeted treatments in cancer. Abou-Jawde R; Choueiri T; Alemany C; Mekhail T Clin Ther; 2003 Aug; 25(8):2121-37. PubMed ID: 14512124 [TBL] [Abstract][Full Text] [Related]
16. [Therapeutic strategies for patients with relapsed acute promyelocytic leukemia]. Ohnishi K Rinsho Ketsueki; 2006 Aug; 47(8):717-23. PubMed ID: 16986710 [No Abstract] [Full Text] [Related]
17. Leukemia, an effective model for chemical biology and target therapy. Chen GQ; Wang LS; Wu YL; Yu Y Acta Pharmacol Sin; 2007 Sep; 28(9):1316-24. PubMed ID: 17723165 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody therapy of leukaemias and lymphomas. Jacobs SA; Foon KA Expert Opin Biol Ther; 2005 Sep; 5(9):1225-43. PubMed ID: 16120052 [TBL] [Abstract][Full Text] [Related]